We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 
The Tecan Group and Luminex Corporation have announced that they will collaborate on the development of a new automated newborn screening solution that will provide faster results for infants' potential health concerns.

The companies have entered into a global OEM agreement that allows them to combine Luminex® xMAP® technology and LX 200™ instrument with Tecan's flexible and reliable Freedom EVO® liquid handling platform and HydroFlex™ washer. The new automated newborn screening solution will help laboratories enhance efficiency, save vital resources and analyze more samples. Luminex expects to launch the automated newborn screening solution in 2011.

Thomas Bachmann, CEO of Tecan, said: "We are delighted that we have been chosen by Luminex to supply a fully automated solution for such an important application. This global OEM agreement is building on a long, well established partnership of creating the most advanced automated solutions in the research market for Luminex xMAP technology."

Luminex xMAP technology enables large numbers of biological tests to be conducted simultaneously and analyzed quickly. Once it receives regulatory clearance, NeoPlex4™ will be a fully automated, walk-away testing platform for multiplexed newborn screening. These high-volume screening assays test newborn infants for several different biomarkers linked to critical diseases.
Advertisement